EDGAR Filing Documents for 0001493152-23-009883

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-23-009883

Filing Date

2023-03-31

Accepted

2023-03-31 06:14:23

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm iXBRL	10-K	1774824
2		ex31-1.htm	EX-31.1	12628
3		ex31-2.htm	EX-31.2	12194
4		ex32-1.htm	EX-32.1	7643
5		ex32-2.htm	EX-32.2	7617
	Complete submission text file	0001493152-23-009883.txt		8250698

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	sign-20221231.xsd	EX-101.SCH	40084
7	XBRL CALCULATION FILE	sign-20221231_cal.xml	EX-101.CAL	51616
8	XBRL DEFINITION FILE	sign-20221231_def.xml	EX-101.DEF	159339
9	XBRL LABEL FILE	sign-20221231_lab.xml	EX-101.LAB	322076
10	XBRL PRESENTATION FILE	sign-20221231_pre.xml	EX-101.PRE	277115
63	EXTRACTED XBRL INSTANCE DOCUMENT	form10-k_htm.xml	XML	1646759

Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212

Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000

Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)